The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

Acne appears at any age, but it’s more common during adolescence and early adulthood. It doesn’t go away with age, but there ...

Seasoned Behavioral Health Leader Joins THIRA Health, Strengthening Commitment to Comprehensive Mental Health Care for Women and Adolescents ...

The prescribing of antiviral drugs for US children and adolescents receiving treatment for influenza was less than 60% in the ...

Treatments for hair regrowth include medicated formulas, supplements, lasers, and complementary remedies, such as massage and ...

Experts say a gaming addiction often points to an underlying mental health condition such as depression. There is also a risk ...

The Mental Health Watchdog calls for reforms to protect public safety, citing decades of antidepressant, electroshock, and psychedelic drug risks.

Widespread support for abortion rights continued to defy partisan labels in the election, but several of the ballot measures that voters approved may face legal and legislative challenges in the ...

OBODENCE™ and XBRYK™ recommended for approval by the European Medicines Agency for all indications referencing Prolia and Xgeva, respectively INCHEON, South Korea, Nov. 15, 2024 (GLOBE NEWSWIRE) -- ...

The decision to discontinue SerpinPC follows the approval of Hympavzi, an antibody-based treatment designed to increase ...

A 2023 Pew Research Center report found that 93 percent of teens aged 13-17 use social media. Parents often have to go to ...

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.